Reveleer, a leading provider of AI-enabled solutions empowering data-driven health plan performance, today announced the launch of Clinical Data Repository, a centralized, AI-enabled clinical data ...
By combining our platform with Trialt’s expertise, we can support sponsors with both the technology and the operational ...
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially ...
Predictive models that combine patient-reported psychosocial measures with clinical data perform well in forecasting flares in patients with inflammatory bowel disease.
Sarepta Therapeutics (NASDAQ:SRPT) stock is up approximately 20% in early trading on Wednesday after the company released its ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
JOURNAVX met the primary endpoint by demonstrating statistically significant superior reduction in pain vs placebo. 1,b JOURNAVX did not meet the first key secondary endpoint that hypothesized ...
A majority of CKD patients present with cellular inflammation and immunoparalysis predose --Gemini durably normalizes ...
Designed to encourage interaction and collaboration, SCOPE X emphasizes detailed case studies, peer-driven discussions, and ...
Jasper Therapeutics, Inc. announced that it is presenting updated clinical data from its Phase 1b/2a BEACON study on briquilimab, an antibody therapy targeting c-Kit to treat mast cell-driven diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results